FDC346.40

FDC Limited

· Pharma & Health
AnnualQuarterly₹ CrorePeersIOLCPMOREPENLABINNOVACAPORCHPHARMASENORESGUJTHEMRPGLIFESANOFIMcap ₹5,640 Cr
View
In ₹ Crore except Per Share
12 Months Ending
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Revenue from Operations1,942.92,108.12,170.92,190.2
Other Income101.690.7113.5139.0
Total Income2,044.62,198.82,284.52,329.2
Expenses
+ Cost of Materials Consumed584.6581.2576.4542.6
+ Purchases of Stock-in-Trade125.1127.4127.6114.8
+ Changes in Inventories-53.527.67.058.0
+ Employee Benefit Expense413.4482.4482.5485.3
+ Finance Costs4.04.55.04.6
+ Depreciation & Amortisation39.953.759.259.5
+ Other Expenses534.9564.7631.3654.1
Total Expenses1,648.41,841.61,889.11,918.9
EBITDA338.5324.8346.1335.5
EBIT298.6271.1286.9276.0
Profit
PBT before Exceptional Items396.2357.2395.4410.3
+ Exceptional Items0.00.0-20.8-20.8
Pretax Income396.2357.2374.6389.5
+ Current Tax88.685.986.491.2
+ Deferred Tax2.64.56.75.8
Tax Expense91.290.493.297.0
Net Income305.1266.8281.4292.6
+ Net Income — Continuing Ops305.1266.8281.4292.6
+ Other Comprehensive Income1.9-1.54.05.6
Total Comprehensive Income306.9265.3285.4298.2
Net Income to Common305.2
Minority Interest-0.2
Per Share
Basic EPS18.5816.3917.2917.98
Diluted EPS18.5816.3917.2917.98
Other Comprehensive Income — detail
+ Other Comprehensive Income-1.54.05.6
+ Items NOT to be Reclassified to P&L1.3-2.71.02.3
+ Tax on Items NOT to be Reclassified-0.40.00.3
+ Tax on Items NOT to be Reclassified — alt tag0.1
+ Items to be Reclassified to P&L0.80.83.1
+ Tax on Items to be Reclassified0.00.0-1.4
Comprehensive Income — Owners of Parent307.2
Comprehensive Income — Non-controlling Interests-0.3
Per Share — as-filed variants
Basic EPS — Continuing Operations18.5816.3917.2917.98
Diluted EPS — Continuing Operations18.5816.3917.2917.98
Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories)
Gross Profit1,286.81,371.81,460.01,474.8
Gross Margin %66.2365.0767.2567.34
Adjusted (ex-Exceptional Items) — derived
Pretax Income (Adjusted, as filed)396.2357.2395.4410.3
− Exceptional Items (reconciliation)0.00.0-20.8-20.8
Net Income Adj (tax-effected)305.1266.8297.0308.2
EPS Adj18.5816.3918.2518.94
Other Filed Concepts — mapped but not yet placed in the schedule
Face Value1.001.001.001.00
Paid Up Equity Capital16.316.316.316.3
As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.